Advertisement
Advertisement
LMAT
LeMaitre Vascular, Inc.
112.61
USDSponsored
+2.86
+2.60%
May 01, 12:00 UTC -4
Open
LMAT Earnings Reports
Positive Surprise Ratio
LMAT beat 27 of 41 last estimates.
66%
Next Report
Next Week
Date of Next Report
May 05, 2026
Estimate for Q1 26 (Revenue/ EPS)
$67.86M
/$0.67
Implied change from Q4 25 (Revenue/ EPS)
+5.29%
/-1.47%
Implied change from Q1 25 (Revenue/ EPS)
+13.34%
/+39.58%
LeMaitre Vascular, Inc. earnings per share and revenue
On Feb 25, 2026, LMAT reported earnings of 0.68 USD per share (EPS) for Q4 25, beating the estimate of 0.67 USD, resulting in a 0.41% surprise. Revenue reached 64.45 million, compared to an expected 64.08 million, with a 0.58% difference. The market reacted with a +24.41% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 11 analysts forecast an EPS of 0.67 USD, with revenue projected to reach 67.86 million USD, implying an decrease of -1.47% EPS, and increase of 5.29% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Baxter International Inc.
Report Date
Apr 30, 2026 For Q1 26
Estimate
$0.31
Actual
$0.36
Surprise
+15.72%
Bio-Rad Laboratories, Inc.Class A
Report Date
Apr 30, 2026 For Q1 26
Estimate
$2.00
Actual
$1.89
Surprise
-5.68%
Stryker Corporation
Report Date
Apr 30, 2026 For Q1 26
Estimate
$3.01
Actual
$2.60
Surprise
-13.75%
Boston Scientific Corp.
Report Date
Apr 22, 2026 For Q1 26
Estimate
$0.79
Actual
$0.80
Surprise
+0.69%
GE HealthCare Technologies Inc. Common Stock
Report Date
Apr 29, 2026 For Q1 26
Estimate
$1.07
Actual
$0.99
Surprise
-7.55%
ResMed Inc.
Report Date
Apr 30, 2026 For Q3 26
Estimate
$2.82
Actual
$2.86
Surprise
+1.20%
Zimmer Biomet Holdings, Inc.
Report Date
Apr 28, 2026 For Q1 26
Estimate
$1.88
Actual
$2.09
Surprise
+10.99%
Cerus Corp
Report Date
Apr 30, 2026 For Q1 26
Estimate
-$0.04
Actual
-$0.01
Surprise
+75.49%
FAQ
What were LeMaitre Vascular, Inc.'s earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, LeMaitre Vascular, Inc. reported EPS of $0.68, missing estimates by 0.41%, and revenue of $64.45M, 0.58% above expectations.
How did the market react to LeMaitre Vascular, Inc.'s Q4 2025 earnings?
The stock price moved up 24.41%, changed from $91.38 before the earnings release to $113.69 the day after.
When is LeMaitre Vascular, Inc. expected to report next?
The next earning report is scheduled for May 05, 2026.
What are the forecasts for LeMaitre Vascular, Inc.'s next earnings report?
Based on 11
analysts, LeMaitre Vascular, Inc. is expected to report EPS of $0.67 and revenue of $67.86M for Q1 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement